Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: Implications for experimental models and clinical studies

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1539-1544

  Negendank, William ^a   Li, Chun Wei ^a   Padavic Shaller, Kristin ^a   Murphy Boesch, Joseph ^a   Brown, Truman R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

31P NMR spectroscopy; Chemical shift imaging; In vivo metabolism; Proton decoupling

Indexed keywords

GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; NUCLEOSIDE TRIPHOSPHATE; PHOSPHOETHANOLAMINE; PHOSPHOLIPID;

ADENOCARCINOMA; CANCER; CONFERENCE PAPER; HUMAN; LYMPHOMA; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SARCOMA; METABOLISM; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; PHOSPHOLIPIDS;

EID: 0029666218     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Negendank W: Studies of human tumors by MRS: a review. NMR Biomed 5: 303-324, 1992.
2. 31P MRS of experimental tumours. NMR Biomed 6: 345-365, 1993.
3. 31P magnetic resonance spectroscopy. Cancer Res 46: 4087-4090, 1986.
4. 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Cancer Res 47: 3396-3401, 1987.
5. Furman E, Margalit R, Bendel P, Horowitz A and Degani H: In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun. 3: 287-297, 1991.
6. 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J Cell Physiol 158: 180-186, 1994.
7. Daly PF, Lyon RC, Faustino PJ and Cohen SC: Phospholipid metabolism in cancer cells monitored by P NMR spectroscopy. J Biol Chem 262: 14875-14878, 1987.
8. Kuesel AC, Graschew G, Hull WE, Lorenz W and Thielmann HW: 31P NMR studies of cultured human tumor cells. Influence of pH on phospholipid metabolite levels and the detection of cytidine 5′-diphosphate choline. NMR Biomed. 3: 78-89, 1990.
9. 31P NMR spectroscopy. NMR Biomed 6: 254-263, 1993.
10. 31P and C resonances. Biochim Biophys Acta 805: 104-116, 1984.
11. Hull WE, Kuesel AC and Pomer S: 31P NMR spectroscopy of human tumor cells in vitro and in vivo: Prospects for applications to renal cell carcinoma. In: Stachler G and Power S (eds). Basic and Clinical Research on Renal Cell Carcinoma, pp. 37-48. Berlin: Springer-Verlag, 1992.
12. 31P chemical shift imaging of the human brain in volunteers. NMR Biomed 6: 173-180, 1993.
13. 1H chemical shift imaging spectroscopy. J Magn Reson (B) 108: 213-219, 1995.
14. Brown TR, Kincaid BM and Ugurbil K: NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 79: 3523-3526, 1982.
15. 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Br J Cancer 63: 953-958, 1991.
16. 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues. Cancer Res 48: 5112-5118, 1988.
17. Barzilai A, Horwitz A, Geier A and Degani II: Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. Cancer 67: 2919-2925, 1991.
18. 31P NMR spectroscopy. NMR Biomed 4: 262-267, 1991.
19. 31P MRS study. Brit J Cancer 67: 1145-1153, 1993.
20. 31P magnetic resonance spectroscopy of human colon cancer. Cancer Res 50: 527-532, 1990.
21. 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed 5: 114-120, 1992.
22. Negendank WG, Padavic-Shaller KA, Li CW, Murphy-Boesch J, Stoyanova R, Krigel, RL, Schilder RS, Smith MS and Brown TR: Metabolic characterization of human non-Hodgkin's lymphomas in vivo using proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res 55: 3286-3294, 1995.
23. 13C- {1H} magnetic resonance spectroscopy of malignant histiocytoma and skeletal muscle tissue in man. NMR Biomed 5: 161-170, 1992.
24. Negendank W, Murphy-Boesch J, Padavic-Shaller K, Li CW, Stoyanova R, Krigel R, Schilder R, Smith M and Brown TR: Phosphomonoester changes and treatment response in lymphomas. Proc Soc Magn Reson 1: 131, 1994.
25. Kaplan O and Cohen JS: Lymphocyte activation and phospholipid pathways. J Biol Chem 226: 3688-3694, 1991.
26. Pelech SL and Vance DE: Signal transduction via phosphatidycholine cycles. Trends Biochem Sci 14: 28-30, 1989.
27. 31P NMR studies. Proc Natl Acad Sci 88: 1506-1510, 1991.
28. Kiss Z, Crilly KS and Anderson WH: Carcinogens stimulate phosphorylation of ethanolamine derived from increased hydrolysis of phosphatidylethanolamine in C3H/1OT/2 fibroblasts. FEBS Lett 336: 115-118, 1993.
29. 31P NMR studies of phospholipid metabolism in lipid-loaded cells. Proc Soc Magn Reson 3: 1364, 1994.
30. Ronen SM, Stier A and Degani H: NMR studies of the lipid metabolism of T47D human breast cancer spheroids. FEBS Lett 266: 147-149, 1990.
31. Freyer JP, Linford H, Lovejoy V and Moore GJ: Correlation between alterations in phosphomonoesters and cellular proliferation during recovery from quiescence in a tumor model. Proc Soc Magn Reson 1: 451, 1994.
32. Sostman HD, Prescott DM, Dewhirst MW, Dodge RK, Thrall DS, Page RL, Tucker JA, Harrelson JM, Reece G, Leopold KA, Oleson JR and Charles HC: MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology 190: 269-275, 1994.